Target-disease evidence and druggability context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
62K gene targets × 23K diseases with evidence-based association scores across 19 data types. 19-dimension target druggability scoring. Literature evidence for 26M gene-paper pairs.
Request context access
Ask us to provision this analytical context into your BigQuery or Snowflake workspace.
Request AccessRelated context
Overview
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
62K gene targets × 23K diseases with evidence-based association scores across 19 data types. 19-dimension target druggability scoring. Literature evidence for 26M gene-paper pairs.
Navigate disease hierarchy, synonym expansion, ontology crosswalks, and gene-disease evidence without manual mapping.
Normalize disease concepts across MeSH, MONDO, DOID, Orphanet, ICD, OMIM, and trial condition text.
Support indication expansion, rare disease strategy, target validation, and literature search use cases.
Join disease concepts to trials, grants, publications, targets, and regulatory indications.
Source authority
Open Targets Platform
Freshness
Last refreshed 2026-07-01
Quarterly
Coverage
7.5M target-disease associations
2 delivery tables